Fresenius is a major player in healthcare, specializing in injectable therapies and hospital operations. Subsidiary Kabi is among the top injectable pharmaceutical providers globally, while the Helios division is the largest private hospital operator in Germany and Spain.
Fresenius benefits from secular growth trends, including an aging population and rising healthcare spending, which are increasing demand for its injectables product portfolio and its hospital services business.
The generic injectables business regularly faces pricing declines, which could constrain growth in the Kabi segment.
|
Metric
|
FRE
|
DVA
|
FMS
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.07 | 13.75 | 8.96 |
Price/Book Value | 1.28 | — | 0.83 |
Price/Sales | 1.08 | 0.88 | 0.55 |
Price/Cash Flow | 10.07 | 5.43 | 4.04 |
|
Metric
|
FRE
|
DVA
|
FMS
|
|---|---|---|---|
Quick Ratio | 0.84 | 1.33 | 0.68 |
Current Ratio | 1.28 | 1.47 | 1.07 |
Interest Coverage | 8.23 | 3.47 | 4.76 |
|
Metric
|
FRE
|
DVA
|
FMS
|
|---|---|---|---|
Return on Assets (Normalized) | 5.09% | 7.71% | 4.50% |
Return on Equity (Normalized) | 11.16% | — | 10.75% |
Return on Invested Capital (Normalized) | 7.34% | 12.79% | 6.66% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Genesis Healthcare Inc Class A
GENNQ
| LOCK|^LD | LOCK|CP | — | |||
| HCA Healthcare Inc
HCA
| LOCK|&t#xXl^ | LOCK|>$yg | $92B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | LOCK|kgc@ | $29B | |||
| Tenet Healthcare Corp
THC
| LOCK|!ZK?#l& | LOCK|l#S< | $20B | |||
| Fresenius Medical Care AG
FMCQF
| — | LOCK|$<q% | $12B | |||
| Fresenius Medical Care AG ADR
FMS
| LOCK|JfH#m?< | LOCK|@S<p | $12B | |||
| Encompass Health Corp
EHC
| — | LOCK|>c>T | $12B | |||
| DaVita Inc
DVA
| LOCK|^t>G^^ | LOCK|$!V&f | $11B | |||
| Universal Health Services Inc Class B
UHS
| LOCK|JfhX>@ | LOCK|Fd#N | $10B | |||
| Ensign Group Inc
ENSG
| — | LOCK|F$bs | $10B |
United States